Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy
Tumor-targeting antibody (Ab)-fused cytokines, referred to as immunocytokines, are designed to increase antitumor efficacy and reduce toxicity through the tumor-directed delivery of cytokines. However, the poor localization and intratumoral penetration of immunocytokines, especially in solid tumors,...
Main Authors: | Keunok Jung, Sojung Yoo, Jung-Eun Kim, Wook Kim, Yong-Sung Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1034774/full |
Similar Items
-
Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy
by: Ana Victoria Casadesús, et al.
Published: (2022-12-01) -
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic
by: Arezoo Beig Parikhani, et al.
Published: (2024-02-01) -
Utilizing Immunocytokines for Cancer Therapy
by: Erin Runbeck, et al.
Published: (2021-03-01) -
Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo
by: Franziska Eckert, et al.
Published: (2017-06-01) -
Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
by: Seung E. Cha, et al.
Published: (2021-01-01)